Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rapak is a global leader in Bag-in-Box packaging and liquid dispensing solutions, serving the healthcare, biopharmaceutical, and food and beverage industries. The company specializes in flexible packaging systems, including sterile bags, liners, and fitments designed for the safe transport and dispensing of clinical fluids, diagnostic reagents, and bulk pharmaceutical ingredients. Rapak's technology focuses on maintaining product integrity through advanced barrier films and aseptic filling capabilities. Formerly a division of DS Smith, Rapak became part of Liquibox under Olympus Partners before being acquired by Sealed Air (SEE) in 2023. Today, it operates as a key brand within Sealed Air's liquid packaging portfolio, providing critical infrastructure for life science supply chains.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rapak.